Regenerative Medical Technology Group Inc. (RMTG) stock
RMTGOTCRetail-Retail Stores, NECFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 3/30
$0.04−0.00 (-5.76%)
Close on Oct 19, 2026Market cap $497.25KP/E –Yield –
Regenerative Medical Technology ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Regenerative Medical Technology's ebitda for the twelve months ending Jun 30, 2026 was $406.65K, down 10.2% year over year. For fiscal 2025 it was -$586.10K, down 294.2% from the year before.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$586.10K | -294.2% |
| FY2024 | Dec 31, 2024 | $301.74K | – |
| FY2023 | Dec 31, 2023 | -$405.12K | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $656.79K | – |
| Q1 FY2026 | Mar 31, 2026 | $327.48K | +75.3% |
| Q4 FY2025 | Dec 31, 2025 | -$207.93K | -158.9% |
| Q3 FY2025 | Sep 30, 2025 | -$369.68K | -440.8% |
| Q2 FY2025 | Jun 30, 2025 | -$195.26K | – |
| Q1 FY2025 | Mar 31, 2025 | $186.77K | – |
| Q4 FY2024 | Dec 31, 2024 | $352.81K | – |
| Q3 FY2024 | Sep 30, 2024 | $108.48K | – |
| Q2 FY2024 | Jun 30, 2024 | -$131.01K | – |
| Q1 FY2024 | Mar 31, 2024 | -$28.53K | – |
See a number that looks wrong?